BCVT has experience in all phases of basic and preclinical research including the development of animal models, diagnostic assays. Leveraging our expansive contacts within academic laboratories, we have access to cutting edge molecular methods including next generation and whole genome sequencing, various “omic” techniques, and other approaches.

We have leveraged these capabilities across the full preclinical pipeline, from establishing and refining animal models of infection to designing and validating the immunogenicity and diagnostic assays needed to evaluate candidate vaccines and therapeutics. Our team combines hands-on laboratory expertise with rigorous study design and applied statistics, ensuring that early-stage findings are robust, reproducible, and translatable to the clinic. By integrating molecular, immunological, and computational approaches, BCVT helps partners de-risk their programs and build the evidence base required to advance promising candidates toward clinical development.